Author:
Lee Jeeyun,Park Joon Oh,Kim Won Seog,Park Se Hoon,Park Keon Woo,Choi Moon Seok,Lee Joon Hyoek,Koh Kwang Cheol,Paik Seung Woon,Yoo Byung Chul,Joh Jaewon,Kim Kihyun,Jung Chul Won,Park Young Suk,Im Young-Hyuck,Kang Won Ki,Lee Mark H.,Park Keunchil
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference25 articles.
1. Al-Idrissi HY, Ibrahim EM, Abdel Satir A, Satti MB, Al-Kasem S, Al-Qurain A (1985) Primary hepatocellular carcinoma in the eastern province of Saudi Arabia: treatment with combination chemotherapy using 5-fluorouracil, adriamycin and mitomycin-C. Hepatogastroenterology 32:8?10
2. Bae JM, Won YJ, Jung KW, Park JG (2002) Annual report of the Korea Central Cancer Registry Program 2000. Cancer Res Treat 34:77?83
3. Boucher E, Corbinais S, Brissot PI, Boudjema K, Raoul JL (2002) Treatment of hepatocellular carcinoma (HCC) with systemic chemotherapy combining epirubicin, cisplatinum and infusional 5-fluorouracil (ECF regimen). Cancer Chemother Pharmacol 50:305?308
4. Chao Y, Chan WK, Birkhofer MK, Chao Y, Chan WK, Birkhofer MJ, Hu OY, Wang SS, Huang YS, Liu M, Whang-Peng J, Chi KH, Lui WY, Lee SD (1998) Phase II and pharmacokinetic study of paclitaxel therapy for unresectable hepatocellular carcinoma patients. Br J Cancer 78:34?39
5. Chlebowski RT, Brezechwa-Adjukiewicz A, Cowden A, Block JB, Tong M, Chan KK (1993) Doxorubicin (75 mg/m2) for hepatocellular carcinoma: clinical and pharmacokinetic results. J Hepatol 18:168?172
Cited by
68 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献